SAN DIEGO, Feb. 8, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences in February:
Tuesday, February 15, 2011 Time:
9:00am Eastern Time (6:00am Pacific Time)Place:
Waldorf Astoria Hotel in New York City Speaker:
Ted Schroeder, President & CEO
Thursday, February 17, 2011Time:
10:05am Eastern Time (7:05am Pacific Time)Place:
Roosevelt Hotel in New York CitySpeaker:
Ted Schroeder, President & CEOEach presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.Contacts:
William R. LaRue
Cadence Pharmaceuticals, Inc.
|SOURCE Cadence Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved